群核科技
KOOL

股本结构

暂无数据

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2019-08-13 241.63 未披露 定期报告 2019-08-09
2019-08-13 236.83 未披露
更多>>
From March 31, 2019 to June 30, 2019 Exercise of pre-funded warrants
2019-06-30
2019-06-04 236.49 未披露
更多>>
Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has amended its Sixth Amended and Restated Certificate of Incorporation to reflect a 1-for-10 reverse stock split of its common stock, which will be effective at 5:00 p.m. Pacific Time on June 4, 2019.
2019-06-05
2019-05-14 2364.91 未披露 定期报告 2019-05-07
2019-05-14 2214.91 未披露
更多>>
from December 31, 2018 to March 31, 2019 Exercise of warrants
2019-03-31
2019-03-26 2214.91 未披露 定期报告 2019-03-25
2019-03-26 2164.91 未披露
更多>>
from December 31, 2017 to September 30, 2018 Stock-based compensation expense Issuance of common stock and pre-funded warrants in financing, net of offering costs Exercise of warrants
2018-09-30
2018-09-19 2164.91 未披露 定期报告 2018-09-13
2018-08-14 2064.91 未披露 定期报告 2018-06-30
2018-05-14 1148.25 未披露 定期报告 2018-05-11
2018-05-14 1148.21 未披露 定期报告 2018-03-31
2018-03-22 1087.24 未披露
更多>>
from June 30, 2017 to December 31, 2017 Stock-based compensation expense, net of stock surrenders Issuance of common shares in financing, net of offering costs Exercise of stock options
2017-12-31
2017-11-14 996.53 未披露 定期报告 2017-11-10
2017-11-14 995.99 未披露 定期报告 2017-09-30
2017-09-22 994.62 未披露 定期报告 2017-09-15
2017-05-12 990.27 未披露 定期报告 2017-05-11
2017-05-12 990.23 未披露 定期报告 2017-03-31
2017-03-23 990.23 未披露 定期报告 2017-03-16
2017-02-13 988.64 未披露 定期报告 2016-12-31
2016-11-17 979.05 未披露 定期报告 2016-09-30
2016-09-21 979.05 未披露
更多>>
On August 22, 2016, the Company elected to convert all outstanding principal and interest accrued and otherwise payable under the Debentures. Upon conversion, 6,102,941 shares of common stock were issued and the Debentures and all security interest and liens were terminated.
2016-09-16
2016-09-21 301.07 未披露
更多>>
From June 30, 2015 to June 30, 2016 Stock-based compensation expense, net of stock surrenders Issuance of common shares and warrants in financing Issuance of common shares for exercise of Series B warrants Common stock issued to directors in lieu of cash compensation On March 4, 2016, the Company effected a one (1) for twenty (20) reverse split of its issued and outstanding common stock. There were no changes to its authorized number of shares of common stock of 350,000,000.
2016-06-30
2016-05-13 300.86 未披露 定期报告 2016-05-10
2016-05-13 300.48 未披露 定期报告 2016-03-31
2016-03-07 300.07 未披露
更多>>
Cesca Therapeutics Inc. (NASDAQ: KOOL), an autologous cell-based regenerative medicine company, has amended its Certificate of Incorporation to reflect a 1-for-20 reverse stock split effective 5:00pm PST on March 4, 2016.
2016-03-07
2016-02-16 6001.34 未披露 定期报告 2016-02-16
2016-02-16 4280.75 未披露 定期报告 2015-12-31
2015-11-16 4067.33 未披露 定期报告 2015-11-12
2015-11-16 4065.33 未披露 定期报告 2015-09-30
2015-09-15 4061.67 未披露 定期报告 2015-09-10
2015-09-17 4050.17 未披露
更多>>
from June 30, 2014 to June 30, 2015 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation
2015-06-30
2015-06-23 4045.34 未披露 定期报告 2015-06-16
2015-05-11 4043.05 未披露 定期报告 2015-04-28
2015-06-24 4041.75 未披露 定期报告 2015-03-31
2015-06-23 4033.79 未披露 定期报告 2014-12-31
2014-11-14 4028.65 未披露 定期报告 2014-09-30
2014-09-29 4026.88 未披露 定期报告 2014-09-26
2014-09-29 4020.05 未披露
更多>>
from June 30, 2013 to June 30, 2014 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation Issuance of common shares & warrants in public offering Issuance of common shares & warrants in private placement Issuance of common shares & warrants pursuant to acquisition Issuance of common shares for repayment of related party notes payable Issuance of common shares for exercise of options
2014-06-30
2014-05-15 3264.14 未披露 定期报告 2014-03-31
2014-04-04 3261.21 未披露 定期报告 2014-03-07
2014-02-14 2003.85 未披露 定期报告 2014-02-07
2014-02-14 1669.24 未披露 定期报告 2013-12-31
2013-11-14 1667.79 未披露 定期报告 2013-09-30
2013-09-04 1666.10 未披露 定期报告 2013-08-28
2013-09-04 1655.76 未披露
更多>>
from June 30, 2012 to June 30, 2013 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation
2013-06-30
2013-05-14 1653.41 未披露 定期报告 2013-03-31
2012-10-23 1652.23 未披露 定期报告 2012-10-16
2012-09-21 1651.82 未披露 定期报告 2012-09-13
2012-09-21 1641.31 未披露
更多>>
from June 30, 2011 to June 30, 2012 Issuance of common shares and compensation related to unrestricted common stock awards Issuance of common shares and compensation related to restricted common stock awards
2012-06-30
2012-02-10 1640.64 未披露 定期报告 2012-02-02
2012-02-10 1638.14 未披露 定期报告 2011-12-31
2011-09-13 1637.14 未披露 定期报告 2011-09-06
2011-05-05 1634.64 未披露 定期报告 2011-03-31
2011-02-11 1409.64 未披露 定期报告 2010-12-31
2010-11-04 1402.33 未披露 定期报告 2010-09-30
2010-09-15 1402.32 未披露 定期报告 2010-06-30
2009-09-11 5609.30 未披露
更多>>
From June 30, 2008 to June 30, 2009 Issuance of common shares and compensation related to unrestricted common stock awards
2009-06-30
2008-09-11 5602.80 未披露
更多>>
From June 30, 2007 to June 30, 2008 Issuance of shares for exercise of options Issuance of common shares and compensation related to common stock restricted awards, net of stock surrenders
2008-06-30
2007-09-13 5570.12 未披露 定期报告 2007-08-29
2007-09-13 5550.05 未披露
更多>>
From June 30, 2006 to June 30, 2007 Issuance of shares for exercise of options and warrants Issuance of common shares and compensation related to common stock restricted awards
2007-06-30
2006-09-07 5489.42 未披露 定期报告 2006-08-30
2006-09-07 5488.30 未披露
更多>>
From June 30, 2005 to June 30, 2006 Issuance of common shares in public offering Issuance of shares for exercise of options and warrants Issuance of common shares to a consultant for services Issuance of common shares and compensation related to common stock restricted awards
2006-06-30
2005-09-12 4591.65 未披露 定期报告 2005-08-26
2005-09-12 4586.02 未披露
更多>>
From June 30, 2004 to June 30, 2005 Issuance of 630,000 common shares upon conversion of Series A preferred stock In January 2005, there were 110,000 shares of Series A Preferred Stock outstanding, which were converted into 550,000 shares of common stock.
2005-06-30
2004-09-13 4484.39 未披露 定期报告 2004-08-20
2004-09-13 4471.19 12.60
更多>>
From June 30, 2003 to June 30, 2004 Issuance of 2,660,000 common shares in private placement Issuance of 2,493,777 shares for exercise of options and warrants
2004-06-30
2003-09-25 3945.99 未披露 定期报告 2003-09-11
2003-09-25 3939.66 15.80
更多>>
From June 30, 2002 to June 30, 2003 Issuance of 3,807,594 common shares in private placement Issuance of 322,251 shares for exercise of options
2003-06-30
2002-09-27 3525.61 未披露 定期报告 2002-09-04
2002-09-27 3523.03 15.80
更多>>
From June 30, 2001 to June 30, 2002 Issuance of 3,504,310 common shares in private placement
2002-06-30
2001-09-28 3180.64 未披露 定期报告 2001-09-17
2001-09-28 3179.48 15.80
更多>>
From June 30, 2000 to June 30, 2001 Issuance of 3,944,047 common shares in private placement Issuance of 2,617,940 common shares upon conversion of Series B preferred stock
2001-06-30
2000-09-27 2623.10 未披露 定期报告 2000-09-15
2000-09-27 2480.41 17.00
更多>>
From June 30, 1999 to June 30, 2000 Issuance of 3,590,000 common shares upon conversion of Series A preferred stock Issuance of 595,322 shares for exercise of options and warrants
2000-06-30
1999-09-27 2080.30 未披露 定期报告 1999-09-17
1999-09-27 2059.75 88.40
更多>>
From June 30, 1998 to June 30, 1999 Issuance of 1,077,540 convertible preferred shares in private placement Issuance of 142,413 common shares for services Issuance of 967,700 common shares upon conversion of preferred stock Issuance of 1,750 common shares for exercise of options Issuance of 560,000 common shares
1999-06-30
1998-09-28 1892.57 未披露
更多>>
From June 30, 1997 to June 30, 1998 Issuance of 5,625 common shares for exercise of warrants Issuance of 268,025 common shares for exercise of options Issuance of 2,786,714 common shares in private placement
1998-06-30
1997-09-29 1586.53 未披露
更多>>
From June 30, 1996 to June 30, 1997 Issuance of 217,500 common shares for exercise of warrants Issuance of 37,250 common shares for exercise of options Issuance of 145,586 common shares for inventory Issuance of 2,756,002 common shares in private placement
1997-06-30
1997-09-29 1270.90 未披露
更多>>
From June 30, 1995 to June 30, 1996 Issuance of 5,000 common shares for exercise of options Issuance of 2,200,000 common shares in private placement Issuance of 326,250 common shares for exercise of warrants
1996-06-30
From March 31, 2019 to June 30, 2019 Exercise of pre-funded warrants
Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has amended its Sixth Amended and Restated Certificate of Incorporation to reflect a 1-for-10 reverse stock split of its common stock, which will be effective at 5:00 p.m. Pacific Time on June 4, 2019.
from December 31, 2018 to March 31, 2019 Exercise of warrants
from December 31, 2017 to September 30, 2018 Stock-based compensation expense Issuance of common stock and pre-funded warrants in financing, net of offering costs Exercise of warrants
from June 30, 2017 to December 31, 2017 Stock-based compensation expense, net of stock surrenders Issuance of common shares in financing, net of offering costs Exercise of stock options
On August 22, 2016, the Company elected to convert all outstanding principal and interest accrued and otherwise payable under the Debentures. Upon conversion, 6,102,941 shares of common stock were issued and the Debentures and all security interest and liens were terminated.
From June 30, 2015 to June 30, 2016 Stock-based compensation expense, net of stock surrenders Issuance of common shares and warrants in financing Issuance of common shares for exercise of Series B warrants Common stock issued to directors in lieu of cash compensation On March 4, 2016, the Company effected a one (1) for twenty (20) reverse split of its issued and outstanding common stock. There were no changes to its authorized number of shares of common stock of 350,000,000.
Cesca Therapeutics Inc. (NASDAQ: KOOL), an autologous cell-based regenerative medicine company, has amended its Certificate of Incorporation to reflect a 1-for-20 reverse stock split effective 5:00pm PST on March 4, 2016.
from June 30, 2014 to June 30, 2015 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation
from June 30, 2013 to June 30, 2014 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation Issuance of common shares & warrants in public offering Issuance of common shares & warrants in private placement Issuance of common shares & warrants pursuant to acquisition Issuance of common shares for repayment of related party notes payable Issuance of common shares for exercise of options
from June 30, 2012 to June 30, 2013 Issuance of common shares and compensation related to restricted common stock awards, net of stock surrenders Common stock issued to directors in lieu of cash compensation
from June 30, 2011 to June 30, 2012 Issuance of common shares and compensation related to unrestricted common stock awards Issuance of common shares and compensation related to restricted common stock awards
From June 30, 2008 to June 30, 2009 Issuance of common shares and compensation related to unrestricted common stock awards
From June 30, 2007 to June 30, 2008 Issuance of shares for exercise of options Issuance of common shares and compensation related to common stock restricted awards, net of stock surrenders
From June 30, 2006 to June 30, 2007 Issuance of shares for exercise of options and warrants Issuance of common shares and compensation related to common stock restricted awards
From June 30, 2005 to June 30, 2006 Issuance of common shares in public offering Issuance of shares for exercise of options and warrants Issuance of common shares to a consultant for services Issuance of common shares and compensation related to common stock restricted awards
From June 30, 2004 to June 30, 2005 Issuance of 630,000 common shares upon conversion of Series A preferred stock In January 2005, there were 110,000 shares of Series A Preferred Stock outstanding, which were converted into 550,000 shares of common stock.
From June 30, 2003 to June 30, 2004 Issuance of 2,660,000 common shares in private placement Issuance of 2,493,777 shares for exercise of options and warrants
From June 30, 2002 to June 30, 2003 Issuance of 3,807,594 common shares in private placement Issuance of 322,251 shares for exercise of options
From June 30, 2001 to June 30, 2002 Issuance of 3,504,310 common shares in private placement
From June 30, 2000 to June 30, 2001 Issuance of 3,944,047 common shares in private placement Issuance of 2,617,940 common shares upon conversion of Series B preferred stock
From June 30, 1999 to June 30, 2000 Issuance of 3,590,000 common shares upon conversion of Series A preferred stock Issuance of 595,322 shares for exercise of options and warrants
From June 30, 1998 to June 30, 1999 Issuance of 1,077,540 convertible preferred shares in private placement Issuance of 142,413 common shares for services Issuance of 967,700 common shares upon conversion of preferred stock Issuance of 1,750 common shares for exercise of options Issuance of 560,000 common shares
From June 30, 1997 to June 30, 1998 Issuance of 5,625 common shares for exercise of warrants Issuance of 268,025 common shares for exercise of options Issuance of 2,786,714 common shares in private placement
From June 30, 1996 to June 30, 1997 Issuance of 217,500 common shares for exercise of warrants Issuance of 37,250 common shares for exercise of options Issuance of 145,586 common shares for inventory Issuance of 2,756,002 common shares in private placement
From June 30, 1995 to June 30, 1996 Issuance of 5,000 common shares for exercise of options Issuance of 2,200,000 common shares in private placement Issuance of 326,250 common shares for exercise of warrants
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。